Autonomic Cardiovascular Control in Response to Blood Volume Reduction in Blood Donors

Sponsor
Hvidovre University Hospital (Other)
Overall Status
Unknown status
CT.gov ID
NCT04499664
Collaborator
(none)
25
1
12
2.1

Study Details

Study Description

Brief Summary

The function of the autonomic nervous system can be assessed using baroreflex sensitivity (BRS) and heart rate variability (HRV). Decreased HRV has been shown to be predictive of morbidity and mortality in diverse medical conditions such as acute myocardial infarction, aneurysmal subarachnoid haemorrhage, autoimmune diseases, sepsis and surgery.

The function of the autonomic nervous system has not yet been investigated in a "pure hypovolemia" model. The aim of the current study is therefore to investigate and describe the function of the autonomic nervous system prior to, during and after reduction of blood volume in healthy blood donors.

Condition or Disease Intervention/Treatment Phase
  • Device: Monitoring of the autonomic nervous system

Study Design

Study Type:
Observational
Anticipated Enrollment :
25 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Autonomic Cardiovascular Control in Response to Blood Volume Reduction in Blood Donors
Actual Study Start Date :
Aug 1, 2020
Anticipated Primary Completion Date :
Aug 1, 2021
Anticipated Study Completion Date :
Aug 1, 2021

Arms and Interventions

Arm Intervention/Treatment
Blood donors

Healhy young male bloddonors, aged 30-45

Device: Monitoring of the autonomic nervous system
Monitoring of the autonomic nervous system using E-patch, LiDCO and Root-Massimo.

Outcome Measures

Primary Outcome Measures

  1. Changes in root mean square of successive NN-interval differences (RMSSD) during mobilisation [15 minutes prior to and 15 minutes after blood donation]

    Measured in ms

Secondary Outcome Measures

  1. Changes in root mean square of successive NN-interval differences (RMSSD) during sleep [The night before and night after blood donation]

    Measured in ms

  2. Changes in standard deviation of N-N intervals (SDNN) during mobilisation [15 minutes prior to and 15 minutes after blood donation]

    Measured in ms

  3. Changes in standard deviation of N-N intervals (SDNN) during sleep [The night before and night after blood donation]

    Measured in ms

  4. Percentage of successive RR intervals that differ by more than 50 ms (pNN50) during mobilisation [15 minutes prior to and 15 minutes after blood donation]

    Measured in %

  5. Percentage of successive RR intervals that differ by more than 50 ms (pNN50) during sleep [The night before and night after blood donation]

    Measured in %

  6. Changes in low frequency (LF) power during mobilisation [15 minutes prior to and 15 minutes after blood donation]

    Measured in ms^2

  7. Changes in low frequency (LF) power during sleep [The night before and night after blood donation]

    Measured in ms^2

  8. Changes high frequency (HF) power during mobilisation [15 minutes prior to and 15 minutes after blood donation]

    Measured in ms^2

  9. Changes high frequency (HF) power during sleep [The night before and night after blood donation]

    Measured in ms^2

  10. Changes in ratio of LF-to-HF power during mobilisation [15 minutes prior to and 15 minutes after blood donation]

    Measured in %

  11. Changes in ratio of LF-to-HF power during sleep [The night before and night after blood donation]

    Measured in %

  12. Changes in S (area of the ellipse which represents total HRV) during mobilisation [15 minutes prior to and 15 minutes after blood donation]

    Measured in ms

  13. Changes in S (area of the ellipse which represents total HRV) during sleep [The night before and night after blood donation]

    Measured in ms

  14. Changes in SD1 (Poincaré plot standard deviation perpendicular the line of identity) during mobilisation [15 minutes prior to and 15 minutes after blood donation]

    Measured in ms

  15. Changes in SD1 (Poincaré plot standard deviation perpendicular the line of identity) during sleep [The night before and night after blood donation]

    Measured in ms

  16. Changes in SD2 (Poincaré plot standard deviation along the line of identity) during mobilisation [15 minutes prior to and 15 minutes after blood donation]

    Measured in ms

  17. Changes in SD2 (Poincaré plot standard deviation along the line of identity) during sleep [The night before and night after blood donation]

    Measured in ms

  18. Changes in SD1/SD2 ratio during mobilisation [15 minutes prior to and 15 minutes after blood donation]

    Measured in ms

  19. Changes in SD1/SD2 ratio during sleep [The night before and night after blood donation]

    Measured in ms

  20. Changes in systolic arterial pressure (SAP) during mobilization [15 minutes prior to and 15 minutes after blood donation]

    Measured in mmHg by non-invasive LiDCO

  21. Changes in diastolic arterial pressure (DAP) during mobilization [15 minutes prior to and 15 minutes after blood donation]

    Measured in mmHg by non-invasive LiDCO

  22. Changes in mean arterial pressure (MAP) during mobilization [15 minutes prior to and 15 minutes after blood donation]

    Measured in mmHg by non-invasive LiDCO

  23. Changes in pulse pressure (PP) during mobilization [15 minutes prior to and 15 minutes after blood donation]

    Measured in mmHg by non-invasive LiDCO

  24. Changes in heart rate (HR) during mobilisation [15 minutes prior to and 15 minutes after blood donation]

    Measured in beats min-1 by non-invasive LiDCO

  25. Changes in cardiac output (CO) during mobilization [15 minutes prior to and 15 minutes after blood donation]

    Measured in L/min by non-invasive LiDCO

  26. Changes in stroke volume (SV) during mobilization [15 minutes prior to and 15 minutes after blood donation]

    Measured in mL by non-invasive LiDCO

  27. Changes in systemic vascular resistance (SVR) during mobilization [15 minutes prior to and 15 minutes after blood donation]

    Measured in dynes s cm-5 by non-invasive LiDCO

  28. Changes in cerebral perfusion (ScO2) during mobilization [15 minutes prior to and 15 minutes after blood donation]

    Measured in % by Root Masimo

  29. Changes in muscular perfusion (SmO2) during mobilization [15 minutes prior to and 15 minutes after blood donation]

    Measured in % by Root Masimo

  30. Changes in peripheral index during mobilization [15 minutes prior to and 15 minutes after blood donation]

    Measured in % by Root Masimo

  31. Concentration of C-reacitve protein [At time of blood donation]

    Measured in gr/dL

  32. V-PLEX Biomarker 54.Plex Kit [Blood taken at time of blood donation]

    54 key analytes that are important in inflammation response and immune system regulation as well as numerous other biological processes

Other Outcome Measures

  1. Pain score [15 minutes prior to and 15 minutes after blood donation]

    Measured by verbal rating scale (VRS) 0 - 10 (0 = no pain, 10 = worse pain imaginable) during mobilisation procedure

Eligibility Criteria

Criteria

Ages Eligible for Study:
30 Years to 45 Years
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Volonteers eligable for blood donation following the Danish legislation

  • Male

  • Age 30-45

  • Written informed consent

  • Speak and understand Danish

Exclusion Criteria:

Volonteers not eligable for blood donation following the Danish legislation, among others due to:

  • Alcohol and drug abuse

  • Cognitive dysfunction

  • Use of anxiolytic or antipsychotic drugs

  • Arrhythmias or heart failure

  • Diabetes mellitus type I

  • Diabetes mellitus type II

  • Use of opioids

  • History of following diseases in the autonomic nervous system: Parkinson disease, multiple sclerosis, autonomic neuropathies

  • History of cerebral apoplexy or transitory cerebral ischemia

  • Dementia

  • American Society of Anesthesiologists (ASA) score ≥ 4

Furthermore:
  • History of orthostatic intolerance and/or orthostatic hypotension

  • Use of following vasodilator antihypertensive drugs: beta-blockers, angiotensin converting enzyme inhibitors (ACEI), angiotensin 2 receptor blockers (ARBs), calcium channel blockers

  • Use of loop diuretics, thiazid diuretics and potassium-sparing diuretics

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hvidovre University Hospital Copenhagen Denmark 2960

Sponsors and Collaborators

  • Hvidovre University Hospital

Investigators

  • Study Director: Henrik Kehlet, Professor, Rigshospitalet, Denmark

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ana-Marija Hristovska, MD, Hvidovre University Hospital
ClinicalTrials.gov Identifier:
NCT04499664
Other Study ID Numbers:
  • H-19069845
First Posted:
Aug 5, 2020
Last Update Posted:
Aug 31, 2020
Last Verified:
Aug 1, 2020
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Ana-Marija Hristovska, MD, Hvidovre University Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 31, 2020